Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
General Information
Revision date
2021-12-03
Product name
THERAFLU CF MAXIMUM STRENGTH HONEY ELDERBERRY DAYTIME
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
Tianjin SmithKline (GSK) Laboratory Co. Ltd.
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H316
Hazard statements
Code
Statements
H316
Causes mild skin irritation
Section 2
SECTION 2: Hazards identification
Emergency overview Causes mild skin irritation.
Hazard statements
categories H316 Causes mild skin irritation.
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 3 See section 11 of the SDS for additional information on health hazards. Prolonged inhalation may be harmful. Causes mild skin irritation. Expected to be a low ingestion hazard. Direct contact with eyes may cause temporary irritation.
Environmental hazards
Not classified. The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Hazard pictograms
None.
Signal word
Warning
Prevention
None.
Response
P332 + P313 If skin irritation occurs: Get medical advice/attention.
Storage
None.
Disposal
None.
Other physicochemical hazards
No unusual fire or explosion hazards noted. The product is stable and non-reactive under normal conditions of use, storage and transport.
Additional information
19.2 % of the mixture consists of component(s) of unknown acute oral toxicity. 42.53 % of the mixture consists of component(s) of unknown acute dermal toxicity. 39.2 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 49.2 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 49.2 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
